PeDRA Pearls

222 Afleveringen

1. Publication Presentation: Care of Congenital Melanocytic Nevi in Newborns and Infants

   Gepubliceerd: 28-6-2022
2. Getting to Know You: Jillian Rork, MD

   Gepubliceerd: 16-6-2022
3. PeDRA at 2022 Society for Investigative Dermatology

   Gepubliceerd: 2-6-2022
4. Hidradenitis Suppurativa Points of Discussion - Episode 3: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Gepubliceerd: 27-5-2022
5. Hidradenitis Suppurativa Points of Discussion - Episode 2: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Gepubliceerd: 27-5-2022
6. Hidradenitis Suppurativa Points of Discussion - Episode 1: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Gepubliceerd: 27-5-2022
7. Getting to Know You: Carrie Coughlin, MD, MPHS

   Gepubliceerd: 18-5-2022
8. Getting to Know You: PeDRA

   Gepubliceerd: 22-4-2022
9. Down Syndrome Points of Discussion - Episode 3: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

   Gepubliceerd: 6-4-2022
10. Down Syndrome Points of Discussion - Episode 2: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Gepubliceerd: 6-4-2022
11. Down Syndrome Subgroup Points of Discussion - Episode 1: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Gepubliceerd: 6-4-2022
12. Getting to Know You: Harper Price, MD

    Gepubliceerd: 18-3-2022
13. Early Investigator Webinar: Imposter No More

    Gepubliceerd: 3-3-2022
14. New Advances in the Treatment of Atopic Dermatitis in Children

    Gepubliceerd: 2-3-2022
15. Getting to Know You: Megha Tollefson, MD

    Gepubliceerd: 16-2-2022
16. Atopic Dermatitis Points of Discussion - Episode 3: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Gepubliceerd: 31-1-2022
17. Atopic Dermatitis Points of Discussion - Episode 2: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Gepubliceerd: 31-1-2022
18. Atopic Dermatitis Points of Discussion - Episode 1: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Gepubliceerd: 31-1-2022
19. Getting to Know You: Beth Drolet, MD

    Gepubliceerd: 19-1-2022
20. Neonatal Skin Points of Discussion- Episode 3: Is Sunscreen Use Safe in Infants under 6 Months?

    Gepubliceerd: 30-12-2021